Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration.
Salomon-Yves CohenMarcel DominguezFlorence CoscasCéline FaureStephanie BaillifHassiba OubrahamLaurent KodjikianMichel Webernull nullPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
ClinicalTrials.gov Identifier: NCT02279537.